Actively Recruiting
To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital
Led by Syeda Sana Zaman · Updated on 2026-01-13
106
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare efficacy of methotrexate vs apremilast in the management of chronic plaque psoriasis.Given the high prevalence of psoriasis in Pakistan and the significant psychological impact on patients, particularly in Peshawer,this study will provide valuable insights into optimal treatment strategies.
CONDITIONS
Official Title
To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 60 years
- Either gender
- Diagnosed with moderate to severe plaque psoriasis with PASI score of 10 or higher
- No systemic therapy for psoriasis in the past 3 months
You will not qualify if you...
- Pregnancy or breastfeeding
- History of liver or kidney dysfunction
- Known allergy to methotrexate or apremilast
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MTI-HMC Peshawar
Peshawar, Khyber Pukhtunkhwa, Pakistan, 25000
Actively Recruiting
Research Team
F
Filza Ajmal, FCPS part 2
CONTACT
G
Ghafoor Ullah
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here